Brief: SWK Holdings Says Unit Receives $5 Mln Milestone Payment From Cara Therapeutics
10/10/2022 21:22
Oct 10 (Reuters) - Cara Therapeutics Inc CARA.O :
* SWK HOLDINGS' SUBSIDIARY, ENTERIS BIOPHARMA, RECEIVES $5
MILLION
MILESTONE PAYMENT FROM CARA THERAPEUTICS
Source text for Eikon: ID:nPn3h8NGva
Further company coverage: CARA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tvardi Therapeutics
See all newsTvardi Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Tvardi Therapeutics Q2 net loss slightly lower estimates
Brief: Tvardi Therapeutics Inc Q2 Net Income USD -6.5 Million Vs. IBES Estimate USD -6.54 Million
Tvardi Therapeutics, Inc. expected to post a loss of 70 cents a share - Earnings Preview
NASDAQ RESUMED AT 07:50 PM